DEEPIKA PAKIANATHAN

CIK 1270734 · last filed 2026-06-16

DEEPIKA PAKIANATHAN is a corporate insider who has filed 67 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for TBPH, was dated Jun 16, 2026. Across all open-market trades the lifetime net is +$5.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions. 18 SEC filings were submitted jointly with JAMES J BOCHNOWSKI.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.17M

Companies

7

Total Filings

67

Lifetime Open-Market Net

$5.89M

Filer Profile

Reported Address

160 BOVET ROAD, SUITE 408
C/O DELPHI VENTURES
SAN MATEO, CA 94402

Related Filers

JAMES J BOCHNOWSKI — 18 joint filings, latest 2016-03-23

DAVID L DOUGLASS — 18 joint filings, latest 2016-03-23

DOUGLAS A ROEDER — 18 joint filings, latest 2016-03-23

DELPHI VENTURES VIII LP — 9 joint filings, latest 2016-03-23

Delphi BioInvestments VIII LP — 9 joint filings, latest 2016-03-23

Delphi Management Partners VIII, L.L.C. — 9 joint filings, latest 2016-03-23

DELPHI BIOINVESTMENTS VI LP — 7 joint filings, latest 2009-10-20

DELPHI MANAGEMENT PARTNERS VI LLC — 7 joint filings, latest 2009-10-20

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
TBPH	Director	64,074	$17.01	$1.09M	$0	7	2026-06-16
KPTI	Director	30,795	$1.61	$49.6K	$1.40M	19	2026-05-26
MREO	Director	105,244	$0.28	$29.5K	-$466.2K	4	2026-02-27
Calithera Biosciences, Inc. (CALA) Delisted	Director	0	$0.00	$0	$4.95M	10	2023-01-31
PARDES BIOSCIENCES, INC. (PRDS) Delisted	Director	30,000	$2.16	$64.8K	$0	2	2021-12-30
ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted	Director	—	—	—	$0	4	2018-05-25
Alexza Pharmaceuticals Inc. (ALXA) Delisted	Director	99,627	—	—	$0	12	2015-06-25

Recent Filings

67 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-06-16	TBPH	Grant (A)	+6,009	$0	EDGAR
2026-05-26	KPTI	Grant (A)	+15,508	$0	EDGAR
2026-02-27	MREO	Grant (A)	—	$0	EDGAR
2025-05-29	KPTI	Grant (A)	—	$0	EDGAR
2025-05-21	TBPH	Grant (A)	+10,649	$0	EDGAR
2025-02-06	MREO	Grant (A)	—	$0	EDGAR
2024-08-23	MREO	Mixed	—	-$315.1K	EDGAR
2024-08-22	—	Notice (144)	−105,244	-$466.2K	EDGAR
2024-06-07	KPTI	Sell (S)	−818,044	-$785.0K	EDGAR
2024-06-04	KPTI	Sell (S)	−906,178	-$880.7K	EDGAR

Showing 1–10 of 67

Page 1 of 7 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.